ADVERTISING

ADVERTISING

Amendments

FCC: improve enforcement and enhance penalties for violations involving illegal robocalls (S. 151), S3075 [23MY]

Health: reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), H3873, H3874, H3876, H3877, H3878, H3879, H3880, H3882, H3883, H3884, H3885, H3886, H3887, H3888, H3889, H3891, H3892, H3893, H3894, H3896, H3897, H3898, H3900, H3901 [16MY]

——— reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), consideration (H. Res. 377), H3811 [15MY]

Bills and resolutions

Corporations: require reporting of disbursements made by foreign nationals for purposes of disseminating political communications and inquire whether persons providing such disbursements are foreign nationals (see H.R. 2853), H4010 [20MY]

Dept. of Agriculture: prohibit certain activities and require greater transparency in commodity check-off programs (see S. 935), S2087 [28MR]

——— prohibit mandatory or compulsory participation of producers in commodity check-off programs (see S. 934), S2087 [28MR]

Dept. of HHS: reauthorize and enhance poison center national toll-free number, media campaign, and grant program (see H.R. 501), H517 [11JA]

——— require drug manufacturers to submit a transparency and justification report prior to increasing certain drug prices (see S. 1391), S2770 [9MY] (see H.R. 2296), H3263 [12AP]

Dept. of Justice: convene an interagency working group to study enforcement of Communications Act provisions relative to restrictions on use of automated telephone equipment (see H.R. 721), H1170 [23JA]

Dept. of Labor: list employers that relocate call centers overseas, make such companies ineligible for Federal grants and loans, and require call center employees to disclose their physical location (see S. 1792), S3362 [12JN] (see H.R. 3219), H4626 [12JN]

——— remove certain restrictions on advertising and public relations by allowing workforce development boards to use Federal resources to advertise their services (see H.R. 2058), H3067 [3AP]

Dept. of Transportation: compel States and ride-hailing companies to require illuminated signs and other safety measures on ride-hailing vehicles and prohibit the sale of such signs (see S. 1871), S3477 [13JN] (see H.R. 3262), H4694 [13JN]

Dept. of Veterans Affairs: improve communications relative to benefits and services for women veterans (see H.R. 2972), H4161 [23MY]

Drugs: decriminalize marijuana, use tax revenues to assist certain small businesses, research effects on driving and health, restrict advertising to protect children, and expunge certain marijuana-related convictions (see S. 1552), S2962 [20MY] (see H.R. 2843), H4009 [20MY]

——— reduce gap between Federal and State marijuana policy (see S. 421), S1133 [7FE] (see H.R. 1119), H1491 [8FE]

——— require disclosure of list prices of prescription drugs and biological products in direct-to-consumer television advertising (see H.R. 3327), H4771 [18JN]

——— require drug manufacturers to disclose prices of prescription drugs in any direct-to-consumer advertising and marketing to practitioners of a drug (see H. Con. Res. 55), H7377 [24JY]

Elections: constitutional amendment permitting Congress and the States to establish limits on contributions and expenditures in elections for public office (see H.J. Res. 39), H1336 [30JA]

——— prohibit interfering in elections with agents of foreign governments, ban foreign nationals from buying digital ads or issue ads, and make aliens convicted of such offenses inadmissible into the U.S. (see S. 1469), S2815 [14MY]

FCC: clarify prohibitions on making robocalls (see H.R. 946), H1348 [4FE] (see H.R. 3375), H5005 [20JN]

——— establish within Enforcement Bureau a division that specifically addresses the issue of robocalls (see S. 1239), S2515 [30AP] (see H.R. 2355), H3283 [25AP]

——— improve enforcement and enhance penalties for violations involving illegal robocalls (see S. 151), S273 [16JA] (see S. 1826), S3475 [13JN] (see H.R. 1602), H2582 [7MR] (see H.R. 2015), H2938 [1AP] (see H.R. 3810), H5999 [17JY]

——— increase existing penalties for provision of misleading or inaccurate caller identification information and extend statute of limitations for forfeiture penalties for persons who commit such violations (see S. 2147), S4907 [17JY]

——— increase penalties for violations involving robocalls, spoofing, and telemarketing (see H.R. 3707), H5726 [11JY]

——— lengthen statute of limitations for enforcing robocall violations (see H.R. 1575), H2504 [6MR]

——— provide evidence of certain robocall violations to Dept. of Justice (see H.R. 3325), H4770 [18JN]

——— provide for additional disclosure requirements for broadcasters that air or transmit content from registered foreign agents (see H.R. 3698), H5725 [11JY]

——— require radio and television broadcasters to provide free broadcasting time for political advertising (see H.R. 896), H1334 [30JA]

FCC/FTC: establish a joint robocaller bounty pilot program (see H.R. 1304), H2038 [15FE]

FDA: amend mission statement to require the agency to address the nation’s prescription opioid addiction epidemic (see S. 417), S1133 [7FE]

——— clarify regulatory framework relative to certain nonprescription drugs that are marketed without an approved new drug application (see H.R. 269), H280 [8JA] (see H.R. 3443), H5075 [24JN]

——— enhance health warnings on cigarette packages, raise minimum age to purchase tobacco products, restrict tobacco flavors, and regulate sale and marketing of all tobacco, including e-cigarettes and accessories (see H.R. 2339), H3274 [18AP]

——— hold pharmaceutical companies accountable for dubious marketing and distribution of opioid products and for their role in creating and exacerbating the opioid epidemic (see S. 1584), S3005 [21MY] (see H.R. 2917), H4118 [22MY]

——— provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad (see S. 2161), S4947 [18JY]

——— restrict direct-to-consumer drug advertising (see H.R. 4106), H7480 [30JY]

FEC: apply restrictions on personal use of campaign funds to political committees, treat certain coordinated expenditures as candidate contributions, and disclose funding source for political advertisements (see H.R. 679), H718 [17JA]

——— enhance transparency and accountability for online political advertisements by requiring those who purchase and publish such ads to disclose information about the advertisements (see S. 1356), S2688 [7MY] (see H.R. 2592), H3500 [8MY]

——— provide political advertising vouchers and payments to defray costs of postage for congressional general election candidates who agree to restrictions on contributions and expenditures (see H.R. 3834), H7150 [18JY]

——— require sponsors of certain general public political advertisements to include in the advertisment information on persons who provided funding for such advertisements (see H.R. 4054), H7466 [25JY]

Federal agencies and departments: report on expenditures for advertising contracts with small disadvantaged businesses and businesses owned by minorities and women (see H.R. 2576), H3500 [8MY]

Financial institutions: limit overdraft fees and establish fair and transparent practices relative to marketing and provision of overdraft coverage programs at depository institutions (see S. 1595), S3058 [22MY]

FTC: eliminate common carrier exemption for telecommunications companies in order to allow investigation of companies that enable illegal robocalling (see S. 2349), S5247 [31JY]

——— establish Office for the Prevention of Fraud Targeting Seniors (see S. 512), S1383 [14FE] (see H.R. 2301), H3263 [12AP]

——— extend, enhance, and revise certain laws on collection, use, and disclosure of personal information of children and establish additional protections (see S. 748), S1792 [12MR] (see H.R. 3900), H7240 [23JY]

——— prescribe rules prohibiting deceptive advertising of abortion services (see H.R. 2646), H3679 [9MY]

——— prohibit unfair and deceptive practice of commercial sexual orientation or gender identity conversion therapy (see S. 2008), S4628 [27JN] (see H.R. 3570), H5257 [27JN]

——— promulgate regulations relative to sensitive personal information or behavioral data (see H.R. 2013), H2938 [1AP]

——— regulate use of automated software programs, or bots, intended to impersonate or replicate human activity on social media and prohibit use of such programs for political advertising (see S. 2125), S4856 [16JY]

Health: modernize prescription verification process for contact lenses and clarify consumer protections regarding false advertising of contact lenses (see H.R. 3975), H7463 [25JY]

——— reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), consideration (see H. Res. 377), H3787 [14MY]

Insurance: require a health insurance issuer offering short-term insurance to disclose certain information on coverage exclusions and premium variations and prohibit sale of such insurance during certain periods (see H.R. 1143), H1517 [11FE]

Medicare/Medicaid: require drug and biological product manufacturers to include truthful and non-misleading pricing information in any direct-to-consumer advertising (see S. 1437), S2787 [13MY]

Patient Protection and Affordable Care Act: provide Federal exchange outreach and educational activities (see H.R. 987), H1389 [6FE]

——— provide for American Health Benefit Exchanges outreach and educational activities (see S. 455), S1275 [12FE]

——— provide funding for American Health Benefit Exchanges navigator programs and outreach and promotional activities (see H.R. 2292), H3263 [12AP]

Political campaigns: prohibit foreign nationals from purchasing a broadcast, cable, or satellite communication that mentions a clearly identified candidate for Federal office (see S. 1962), S4504 [25JN] (see H.R. 2135), H3128 [8AP]

——— provide for additional disclosure requirements for corporations, labor organizations, and other entities (see S. 1147), S2433 [11AP] (see H.R. 2977), H4162 [23MY]

——— reform financing of Senate elections (see S. 2257), S5062 [24JY]

Taxation: amend definition of qualified amateur sports organization in the Internal Revenue Code to remove restriction on student-athletes using or being compensated for use of their name, image, or likeness (see H.R. 1804), H2745 [14MR]

——— prohibit deduction for prescription drug advertising and promotional expenses (see S. 73), S141 [10JA]

Letters

Over-the-Counter Drug Safety, Innovation, and Reform Act: Senator Braun, S1893 [14MR]

Stopping Bad Robocalls Act: Nancy A. LeaMond, AARP (organization), H7301 [24JY]

——— several consumer organizations, H7302 [24JY]

Motions

Health: reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), H3904 [16MY]

Notices

Estimated budget effects of H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act, H3786 [14MY], H3921 [16MY]

Estimated budget effects of H.R. 3375, Stopping Bad Robocalls Act, H7375 [24JY]

Intention to object to H.R. 269, Pandemic and All-Hazards Preparedness and Advancing Innovation Act: Senator Braun, S1910 [14MR]

Remarks in House

Dept. of HHS: reauthorize and enhance poison center national toll-free number, media campaign, and grant program (H.R. 501), H2052, H2053 [25FE]

——— report on Patient Protection and Affordable Care Act marketing and outreach programs, H3877 [16MY]

——— report on use of Patient Protection and Affordable Care Act user fees to fund outreach and enrollment, navigator program, and maintenance of Healthcare.gov and its call centers, H3897 [16MY]

Dept. of Justice: convene an interagency working group to study enforcement of Communications Act provisions relative to restrictions on use of automated telephone equipment, H7297, H7300, H7301 [24JY]

Elections: constitutional amendment permitting Congress and the States to establish limits on contributions and expenditures in elections for public office (H.J. Res. 39), E114 [30JA]

FCC: clarify prohibitions on making robocalls (H.R. 3375), H7292–H7303 [24JY], H7384 [25JY]

——— improve enforcement and enhance penalties for violations involving illegal robocalls, H7301 [24JY]

——— improve enforcement and enhance penalties for violations involving illegal robocalls (H.R. 2015), H4013 [21MY]

——— increase penalties for violations involving robocalls, spoofing, and telemarketing (H.R. 3707), H7384 [25JY]

——— lengthen statute of limitations for enforcing robocall violations (H.R. 1575), H2655 [12MR]

——— provide evidence of certain robocall violations to Dept. of Justice, H7297, H7300, H7301 [24JY]

——— require radio and television broadcasters to provide free broadcasting time for political advertising (H.R. 896), E114 [30JA]

FDA: clarify regulatory framework relative to certain nonprescription drugs that are marketed without an approved new drug application (H.R. 269), H237–H266 [8JA]

——— clarify regulatory framework relative to certain nonprescription drugs that are marketed without an approved new drug application (H.R. 3443), E971, E977 [24JY]

FEC: enhance transparency and accountability for online political advertisements by requiring those who purchase and publish such ads to disclose information about the advertisements, H2400 [6MR]

Federal agencies and departments: report on expenditures for advertising contracts with small disadvantaged businesses and businesses owned by minorities and women (H.R. 2576), E559 [8MY]

FTC: enforcement actions against companies that fail to protect personal information of children funding, H5179 [26JN]

Health: reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), H3715 [10MY], H3731 [14MY], H3800 [15MY], H3851, H3852, H3853–H3911, H3913 [16MY], H4123 [23MY], H4401 [11JN], H5085 [25JN], H5175 [26JN], E623 [17MY]

——— reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), consideration (H. Res. 377), H3801–H3813 [15MY]

——— reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), corrections in engrossment, H3911 [16MY]

——— reduce prescription drug prices, facilitate entry of generic and biosimilar products into the market, strengthen Federal exchanges, and reverse extension of short-term health plans (H.R. 987), motion to recommit, H3908, H3909 [16MY]

Insurance: require a health insurance issuer offering short-term insurance to disclose certain information on coverage exclusions and premium variations and prohibit sale of such insurance during certain periods, H3895, H3896, H3898 [16MY]

Political campaigns: expand ban on foreign contributions and expenditures on U.S. elections to include purchasing advertisements on digital media or television, H2569 [7MR]

——— provide for additional disclosure requirements for corporations, labor organizations, and other entities, H2383, H2401 [6MR]

Remarks in Senate

Drugs: require disclosure of list prices of prescription drugs and biological products in direct-to-consumer television advertising, S3809 [19JN], S4707 [9JY], S4831 [16JY]

——— require drug manufacturers to disclose prices of prescription drugs in any direct-to-consumer advertising and marketing to practitioners of a drug, S1865 [14MR], S2733 [8MY], S3177 [4JN]

Elections: prohibit interfering in elections with agents of foreign governments, ban foreign nationals from buying digital ads or issue ads, and make aliens convicted of such offenses inadmissible into the U.S. (S. 1469), S2833 [14MY], S5098 [25JY], S5153 [30JY]

FCC: improve enforcement and enhance penalties for violations involving illegal robocalls (S. 151), S2298 [9AP], S3073–S3077, S3082–S3084 [23MY]

——— increase existing penalties for provision of misleading or inaccurate caller identification information and extend statute of limitations for forfeiture penalties for persons who commit such violations (S. 2147), S4912 [17JY]

FDA: clarify regulatory framework relative to certain nonprescription drugs that are marketed without an approved new drug application (H.R. 269), S106 [9JA], S111 [10JA]

——— hold pharmaceutical companies accountable for illegal marketing and distribution of opioid products and for their role in creating and exacerbating the opioid epidemic, S4883–S4885 [17JY]

FEC: enhance transparency and accountability for online political advertisements by requiring those who purchase and publish such ads to disclose information about the advertisements (S. 1356), S5282, S5284 [1AU]

FTC: eliminate common carrier exemption for telecommunications companies in order to allow investigation of companies that enable illegal robocalling (S. 2349), S5252 [31JY]

——— extend, enhance, and revise certain laws on collection, use, and disclosure of personal information of children and establish additional protections, S4789 [11JY]

——— prohibit unfair and deceptive practice of commercial sexual orientation or gender identity conversion therapy (S. 2008), S4631 [27JN]

Political campaigns: provide for additional disclosure requirements for corporations, labor organizations, and other entities, S107 [9JA], S1317 [13FE]

Taxation: prohibit deduction for prescription drug advertising and promotional expenses, S5126 [29JY]

——— prohibit deduction for prescription drug advertising and promotional expenses (S. 73), S5221 [31JY]

Reports filed

Consideration of H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act: Committee on Rules (House) (H. Res. 377) (H. Rept. 116–61), H3787 [14MY]

Marketing and Outreach Restoration To Empower (MORE) Health Education Act: Committee on Energy and Commerce (House) (H.R. 987) (H. Rept. 116–53), H3725 [10MY]

Stopping Bad Robocalls Act: Committee on Energy and Commerce (House) (H.R. 3375) (H. Rept. 116–173), H7239 [23JY]

Telephone Robocall Abuse Criminal Enforcement and Deterrence (TRACED) Act: Committee on Commerce, Science, and Transportation (Senate) (S. 151) (S. Rept. 116–41), S3004 [21MY]

Statements

Stopping Bad Robocalls Act: several consumer and privacy organizations, H7302 [24JY]

Tables

Estimated pay-as-you-go effects of H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act, H3786 [14MY], H3921 [16MY]

Texts of

H. Res. 377, consideration of H.R. 5, Equality Act, H.R. 312, Mashpee Wampanoag Tribe Reservation Reaffirmation Act, and H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act, H3801 [15MY]

H.R. 501, Poison Center Network Enhancement Act, H2052 [25FE]

H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act, H3868–H3873 [16MY]

H.R. 3375, Stopping Bad Robocalls Act, H7293–H7296 [24JY]

S. 151, Telephone Robocall Abuse Criminal Enforcement and Deterrence (TRACED) Act, S276 [16JA], S3075 [23MY]

S. 1437, Drug-Price Transparency in Communications (DTC) Act, S2791 [13MY]

S. 1552, Marijuana Freedom and Opportunity Act, S2971 [20MY]

S. 2257, Fair Elections Now Act, S5065–S5070 [24JY]